Cambridge Investment Research Advisors
AMN icon

Cambridge Investment Research Advisors’s AMN Healthcare AMN Stock Holding History

Cambridge Investment Research Advisors’s Portfolio AMN Stock Details AMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-86,308
Closed -$1.58M – 4045
2026
Q1 		$1.58M Buy
+86,308
New +$1.64M ﹤0.01% 1792
2024
Q4 		– Sell
-53,482
Closed -$2.27M – 3468
2024
Q3 		$2.27M Buy
53,482
+5,616
+12% +$294K 0.01% 1256
2024
Q2 		$2.45M Buy
47,866
+44,555
+1,346% +$2.52M 0.01% 1153
2024
Q1 		$207K Sell
3,311
-4,936
-60% -$336K ﹤0.01% 2999
2023
Q4 		$618K Sell
8,247
-49,966
-86% -$3.57M ﹤0.01% 2017
2023
Q3 		$4.96M Buy
58,213
+54,171
+1,340% +$5.14M 0.02% 653
2023
Q2 		$441K Buy
4,042
+93
+2% +$8.82K ﹤0.01% 2229
2023
Q1 		$328K Sell
3,949
-259
-6% -$24.4K ﹤0.01% 2408
2022
Q4 		$433K Buy
4,208
+1,893
+82% +$218K ﹤0.01% 2132
2022
Q3 		$245K Buy
2,315
+253
+12% +$27.7K ﹤0.01% 2537
2022
Q2 		$226K Sell
2,062
-1,809
-47% -$179K ﹤0.01% 2615
2022
Q1 		$404K Buy
+3,871
New +$402K ﹤0.01% 2283
2021
Q4 		– Sell
-15,219
Closed -$1.75M – 3167
2021
Q3 		$1.75M Buy
15,219
+8,118
+114% +$861K 0.01% 1175
2021
Q2 		$689K Sell
7,101
-16,362
-70% -$1.42M ﹤0.01% 1806
2021
Q1 		$1.73M Buy
23,463
+9,939
+73% +$739K 0.01% 1084
2020
Q4 		$923K Buy
+13,524
New +$882K 0.01% 1360
2019
Q2 		– Sell
-15,375
Closed -$724K – 2207
2019
Q1 		$724K Buy
15,375
+10,570
+220% +$586K 0.01% 1237
2018
Q4 		$272K Sell
4,805
-320
-6% -$17.9K ﹤0.01% 1717
2018
Q3 		$280K Sell
5,125
-13,749
-73% -$787K ﹤0.01% 1835
2018
Q2 		$1.11M Buy
18,874
+350
+2% +$20.9K 0.01% 922
2018
Q1 		$1.05M Buy
18,524
+13,101
+242% +$712K 0.01% 913
2017
Q4 		$267K Buy
+5,423
New +$247K ﹤0.01% 1733

Other funds holding AMN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Cambridge Investment Research Advisors's AMN Position: Q2 2026 in Review

Cambridge Investment Research Advisors sold out of AMN Healthcare (AMN) in Q2 2026, closing a stake of 86,308 shares — an estimated $1.58M sold.

Cambridge Investment Research Advisors first reported a position in AMN in Q4 2017 and held it in 22 quarters. The position peaked at $4.96M in Q3 2023. 285 funds tracked by Wall St. Rank hold AMN as of Q2 2026.

  • Cambridge Investment Research Advisors reported no remaining AMN Healthcare position as of Q2 2026 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 86,308 AMN Healthcare shares in Q2 2026, an estimated $1.58M.
  • Cambridge Investment Research Advisors first reported a position in AMN Healthcare in Q4 2017 and held it in 22 quarters.
  • Cambridge Investment Research Advisors's AMN Healthcare position peaked at $4.96M in Q3 2023.
  • 285 funds tracked by Wall St. Rank held AMN Healthcare as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.